MARATTO

preprint · Research Square (Research Square)

Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, prior to the SARS-CoV-2 pandemic, South Africa, 2012 – 2018

Abstract

<title>Abstract</title> <bold>Background</bold> Identifying risk factors for respiratory syncytial virus (RSV)–associated severe acute respiratory illness (SARI) will assist with targeting vaccine interventions. <bold>Methods</bold> Using surveillance data from South Africa (2012-2018). We compared the characteristics of individuals with RSV-associated ILI (reference group) to those with RSV-associated SARI to describe factors associated with SARI using a multivariable analysis. <bold>Results</bold> RSV was detected in 6% (483/7792) of ILI cases and 15% (844/5672) of SARI cases. Factors associated with SARI in children included age &lt;2 months, compared to age 2–4 years (adjusted odds ratio (aOR) 54.4; 95% confidence interval (CI) 23.5–125.8), malnutrition (aOR 1.9; 95% CI 1.2–3.2), prematurity (aOR 2.4; 95% CI 1.3–4.6) and living with HIV (LWH) (aOR 22.5; 95% CI 2.9–174.3). In individuals ≥5 years, factors associated with SARI included age ≥65 years compared to age 5–24 years (aOR 10.7; 95% CI 1.1–107.5), symptom duration ≥5 days (aOR 2.7; 95% CI 1.1–6.3), underlying illness (aOR 2.7; 95% CI 1.5–26.1) and LWH (aOR 16.8, 95% CI: 4.8–58.2). <bold>Conclusion</bold> Individuals at the extremes of age and those with identified risk factors a might benefit most from RSV prevention interventions.

Research topics

  • Respiratory viral infections research
  • Tracheal and airway disorders
  • Pneumonia and Respiratory Infections

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-4466785/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.